Therapies
Engineered synthetic peptides, compositions containing them, and methods of their use in the treatment of malignant gliomas
Patent inventors: Katarzyna Poleszak, Maria Pasierbińska, Aleksandra Ellert-Miklaszewska, Paulina Pilanc-Kudlek, Paweł Wiśniewski, Bożena Kamińska-Kaczmarek

The invention concerns isolated peptides, compositions and methods of use for treating tumors infiltrated with macrophages, such as glioblastomas. Peptides target osteopontin (SPP1, OPN) protein.

Nencki Institute is the sole applicant.

For more information contact Technology Transfer Office.

Application number:
P.441229 (19 May 2022), PCT/IB2023/055089 (17 May 2023)
Patent status:
pending